US healthcare access gaps could block equitable cancer cure delivery

Ted Okon, a US healthcare advocate, argues that even if a cancer cure were developed, the fragmented US system would fail to deliver it equitably due to cost and access barriers. The claim highlights systemic weaknesses rather than a specific medical breakthrough. This matters because it frames future cancer treatment advances within existing healthcare inequities.